Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Earnings and Comprehensive Income

v3.19.2
Consolidated Statements of Earnings and Comprehensive Income - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2017
Net sales $ 714,006 $ 642,993 $ 563,003
Cost of sales 240,515 210,850 188,462
Gross margin 473,491 432,143 374,541
Operating expenses:      
Selling, general and administrative 264,359 240,636 200,443
Research and development 62,413 55,329 53,514
Total operating expenses 326,772 295,965 253,957
Operating income 146,719 136,178 120,584
Other income (expense):      
Interest expense (21,705) (10,188) (7,361)
Interest income 569 409 304
Other non-operating income (expense), net (13,568) (447) (1,566)
Total other income (expense), net (34,704) (10,226) (8,623)
Income before income taxes 112,015 125,952 111,961
Income taxes (benefit) 15,942 (198) 35,875
Net earnings 96,072 126,150 76,086
Other comprehensive income (loss):      
Foreign currency translation adjustments (4,487) (1,572) (3,061)
Unrealized gains (losses) on derivative instruments - cash flow hedges, net of tax of $2,921 in FY19 (9,537)    
Unrealized gains (losses) on available-for-sale investments, net of tax of $398 in FY18 and $(6,501) in FY17 5,693 24,531
Other comprehensive income (loss) (14,024) 4,121 21,470
Comprehensive income $ 82,048 $ 130,271 $ 97,556
Earnings per share:      
Basic (in dollars per share) $ 2.54 $ 3.36 $ 2.04
Diluted (in dollars per share) $ 2.47 $ 3.31 $ 2.03
Weighted average common shares outstanding:      
Basic (in shares) 37,781 37,476 37,313
Diluted (in shares) 38,892 38,055 37,500